Want to see AU:SHG full AI Analyst Report?
SHG Stock Chart & Stats
AU$0.26
AU$0.03(15.38%)
At close: 4:00 PM EST
AU$0.26
AU$0.03(15.38%)
Day’s Range― - ―
52-Week RangeAU$0.17 - AU$0.36
Previous CloseN/A
Volume808.83K
Average Volume (3M)1.03M
Market Cap
AU$61.61M
Enterprise ValueAU$60.72M
Total Cash (Recent Filing)AU$11.06M
Total Debt (Recent Filing)AU$113.71K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding324,273,100
10 Day Avg. Volume889,327
30 Day Avg. Volume1,029,223
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)6.82
Price to Sales (P/S)160.16
P/FCF Ratio-37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Balance Sheet (zero Debt)The reported zero debt position and a large equity base in 2025 materially reduce near-term refinancing and interest-rate risk. That balance sheet flexibility supports operational continuity and gives management time to execute strategy or seek non-debt funding without immediate liquidity pressure.
Predictable Cash Burn Relative To LossesFree cash flow closely tracking net losses implies the company’s cash outflows move in step with accounting losses, improving predictability of funding needs. Predictable burn supports better capital planning, clearer runway estimates, and more effective timing of financing or restructuring actions.
Market Exposure To Healthcare ITOperating in healthcare information services positions the company within a structurally growing market driven by digitization and demand for clinical data solutions. Durable industry demand can provide sustained addressable market opportunities for recurring revenues and product adoption over the medium term.
Bears Say
Persistent Losses And Very Negative MarginsSustained multi-year losses and extremely negative margins indicate the business has not reached a viable profitability model. Over months, this undermines internal reinvestment capacity, heightens dependence on external capital, and makes durable margin improvement a prerequisite for long-term viability.
Sharp 2025 Revenue Decline (~36% YoY)A steep year-over-year revenue drop signals unstable demand or execution problems. Such top-line volatility impairs scaling economics, complicates forecasting and product investment decisions, and raises the risk that fixed-cost structure will remain mismatched to sustainable revenue levels.
Weak Cash Generation And Ongoing Cash BurnPersistent negative operating cash flow and a 2025 FCF deterioration show the company is not self-funding and faces ongoing cash consumption. This creates structural financing risk, potential dilution from future raises, and constrains investment in product development or sales necessary for durable growth.
Singular Health Group Ltd News
SHG FAQ
What was Singular Health Group Ltd’s price range in the past 12 months?
Singular Health Group Ltd lowest share price was AU$0.17 and its highest was AU$0.36 in the past 12 months.
What is Singular Health Group Ltd’s market cap?
Singular Health Group Ltd’s market cap is AU$61.61M.
When is Singular Health Group Ltd’s upcoming earnings report date?
Singular Health Group Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 13 days.
How were Singular Health Group Ltd’s earnings last quarter?
Singular Health Group Ltd released its earnings results on Feb 23, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.
Is Singular Health Group Ltd overvalued?
According to Wall Street analysts Singular Health Group Ltd’s price is currently Overvalued.
Does Singular Health Group Ltd pay dividends?
Singular Health Group Ltd does not currently pay dividends.
What is Singular Health Group Ltd’s EPS estimate?
Singular Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Singular Health Group Ltd have?
Singular Health Group Ltd has 324,273,100 shares outstanding.
What happened to Singular Health Group Ltd’s price movement after its last earnings report?
Singular Health Group Ltd reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of Singular Health Group Ltd?
Currently, no hedge funds are holding shares in AU:SHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Singular Health Group Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
252.94%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
145.48%
Trailing 12-Months
Company Description
Singular Health Group Ltd
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.
Technical Analysis
Mach7 Technologies
―
Resonance Health Ltd
―
Beamtree Holdings Ltd
―
Artrya Limited
―
Alcidion Group Limited
―